Abstracts - faqs.org

Abstracts

Zoology and wildlife conservation

Search abstracts:
Abstracts » Zoology and wildlife conservation

Genetic organization of a chimpanzee lentivirus related to HIV-1

Article Abstract:

Viruses that are similar to HIV 1 (human immunodeficiency virus, type 1), which causes AIDS (autoimmune deficiency syndrome), have been isolated from various strains of monkeys and other animals. These are called simian immunodeficiency viruses (SIV), and are acutally more closely related to HIV 2, which doesn't cause AIDS, than HIV 1. Recently a simian virus that more closely resembles HIV 1 has been demonstrated. They call this virus SIV (subscript cpz), and, although similar to HIV 1 in its overall genetic organization, it was found to represent yet another of the many distinct simian lentiviruses believed to exist. This was concluded because of the many divergent proteins that emerged during coding of the genetic material, and these findings are discussed in detail in the article. (Consumer Summary produced by Reliance Medical Information, Inc.)

Author: Wain-Hobson, Simon, Huet, Thierry, Cheynier, Remi, Meyerhans, Andreas, Roelants, George
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1990
Diseases, Genetic aspects, Origin, Chimpanzees, Simian immunodeficiency virus

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


One on one meets two

Article Abstract:

The entry of HIV into the host cells is aided by the transmembrane and surface proteins, gp120 and gp41, respectively. They are the enzyme-cleavaged products of an HIV-encoded glycoprotein precursor, gp160. The surface protein gp120 recognizes the host CD4 receptor and undergoes a transformational change allowing it to bind to the second receptor, CCR-5. The amino terminus of gp41 is exposed and the host cell membrane is penetrated by the HIV. HIV penetration of host cells even in the absence of CD-4 cells occurs probably due to genetic complexity of high-titre virus numbers.

Author: Wain-Hobson, Simon
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1996
Research, HIV infection, HIV infections, Virus receptors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Down or out in blood and lymph?

Article Abstract:

Research scientists now believe that a full-blown human immunodeficiency virus (HIV) infection can be destroyed within three years though the use of multiple drug treatment. The combined usage of HIV inhibitors such as the protease inhibitor nelfinavir with extant pharmaceuticals to oppose viral reverse transcriptase appears to be very effective at systematically reducing the number of infections HIV virions in the bloodstream.

Author: Wain-Hobson, Simon
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1997
Care and treatment, Usage, Prevention, AIDS patients, Drug therapy, Combination, Combination drug therapy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: HIV (Viruses), HIV
Similar abstracts:
  • Abstracts: The wealth of nations. Origins of major human infectious diseases. Unwritten knowledge: Preliterate societies depend on the wise words of the older generations
  • Abstracts: Ape populations decimated by hunting and Ebola virus. Order out of chaos. Vital signs
  • Abstracts: Transgenerational induction of defences in animals and plants. The impact of ultraviolet radiation on the vertical distribution of zooplankton of the genus Daphnia
  • Abstracts: The osmium isotopic composition of the Earth's primitive upper mantle. The Earth's mantle
  • Abstracts: Destabilizaiton of Beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. An inflammatory drug prospect
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.